Pre-market
You're reading the free version. Trader adds the live tape and alerts. Start tracking

1 trade

Disclosure transactions for Nasus Pharma Ltd
Reporting person Filed Transaction Transaction value Source Actions
Teleman Dan Benjamin Chief Executive Officer Jun 22, 2026 5-day lag Buy Jun 17, 2026 $20.3K Filed shares x price SEC Form 4 View filing
Teleman Dan Benjamin Chief Executive Officer
Buy
Calculated transaction value
$20.3K 6,550 shares @ $3.1
Traded
Jun 17, 2026
Filed
Jun 22, 2026